Loading...
In the Press2020-01-22T11:31:25+01:00

In the press

1501, 2015

Global media coverage “Pfizer acquires Redvax GmbH, a spin-off from Redbiotec”

January 15th, 2015|

We are pleased with the global media coverage of the acquisition of our spin-off company Redvax GmbH by Pfizer Inc.. This transaction provides access to a preclinical human cytomegalovirus (CMV) vaccine candidate, as well as intellectual property and a technology platform related to a second, undisclosed vaccine program.

Coverage of “Pfizer-Redvax deal” by selected media:

Pfizer Inc.

WSJ

MarketWatch

Nasdaq